While for patients with low CD8+ tumor-infiltrating T cells, a poorer OS was detected in those with positive PD-L1 expression than those with negative PD-L1 expression, showing that PD-L1 expression on immune cells rather than tumor cells was associated with a better outcome for HNSCC (51, 57). Here, CD8A is linked to head and neck squamous cell carcinoma.